Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics.

Bogen JP, Grzeschik J, Jakobsen J, Bähre A, Hock B, Kolmar H

Open source

DOI
10.3389/fonc.2021.672262
Published
2021
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.672262,
  title = {Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics.},
  author = {Bogen JP and Grzeschik J and Jakobsen J and Bähre A and Hock B and Kolmar H},
  year = {2021},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2021.672262},
  url = {https://doi.org/10.3389/fonc.2021.672262}
}

RIS

TY  - JOUR
TI  - Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics.
AU  - Bogen JP
AU  - Grzeschik J
AU  - Jakobsen J
AU  - Bähre A
AU  - Hock B
AU  - Kolmar H
PY  - 2021
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2021.672262
UR  - https://doi.org/10.3389/fonc.2021.672262
ER  - 

APA

JP, B., J, G., J, J., A, B., B, H., & H, K. (2021). Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics.. Frontiers in oncology. https://doi.org/10.3389/fonc.2021.672262

Source records